RAD51C and breast cancer: For RAD51C, a higher BC relative risk in younger women aged 20–49 years (RR = 2.42; 95% CI: 1.61–3.63) was observed compared with older women ≥50 years (RR = 1.36, 95% CI: 0.70–2.63).